PAX — Paxman AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK1.15bn
- SEK1.05bn
- SEK313.35m
Brief: Paxman Opens Cipn Clinical Trial With National University Hospital, Singapore
Brief: Paxman Signs Agreements With Partners In Indonesia And Bangladesh
Brief: Paxman Q1 EBITDA Falls To SEK 0.4 Mln
Brief: Paxman Signs Two New Partners For Chile And Ukraine
Brief: Paxman Q4 EBITDA Loss Widens To SEK 3.3 Mln
Brief: Paxman Gets About SEK 59 Mln Before Transaction Costs In Directed Issue
Brief: Paxman Gets Order For 10 Scalp Cooling Systems For The Italian Market
Brief: Paxman Q3 EBITDA Swings To Loss Of SEK 0.1 Mln
Brief: Paxman Q2 EBITDA Falls To SEK 0.9 Million
Brief: Nordic Asset Manager Bankinvest Buys 200,000 Shares In Paxman
Brief: Paxman Q4 EBITDA Loss Narrows To SEK 0.8 Mln
Brief: Paxman And University Of Huddersfield Invest SEK 12 Mln Over 5 Years
Brief: Paxman Signs Research Collaboration Agreement With National University Hospital, Singapore
Brief: Paxman Gets Second Order From Teva In Mexico
Brief: Paxman Q3 Net Loss Narrows To SEK 0.3 Million
Brief: Paxman Q2 Net Sales Grow To SEK 12.6 Million
Brief: Paxman Receives First Order From Teva In Mexico
Brief: Paxman comments on AMA decision on CPT code for scalp cooling
Brief: Paxman Q1 Operating Loss Narrows To SEK 1.6 Million